摘要
目的:对茵陈蒿汤联合双黄连粉针在母儿ABO血型不合治疗中的价值进行研究,为临床治疗提供指导。方法:将126例研究对象随机分为对照和观察两个研究组,分别予以茵陈蒿汤及其联合双黄连粉针进行治疗,治疗后就其疗效进行组间比较。结果:观察组总有效率为93.8%,高于对照组的80.6%,且具有显著差异性(P<0.05)。结论:茵陈蒿汤联合双黄连粉针在母儿ABO血型不合治疗中具有显著的疗效,具有推广价值。
Objective: Clinical values of the Yinchenhao decoction plus the Shuanghuanglian injection on maternal.fetal ABO blood group incompatibility were researched for more reference. Methods: 126 cases of research objects were randomly divided into the control group and the observed group. The control group was given the Yinchenhao decoction; and the observed group received the Yinchenhao decoction plus the Shuanghuanglian injection. Results: The total efficiency was 93.8% in the observed group, and 80.6% in the control group, with statistical difference(P〈0.05). Conclusion: The Yinchenhao decoction plus the Shuanghuanglian injection was significantly effective on maternal.fetal ABO blood group incompatibility, and worthy of promotion.
出处
《中医临床研究》
2016年第13期114-115,共2页
Clinical Journal Of Chinese Medicine
关键词
茵陈蒿汤
双黄连粉针
母儿ABO血型不合
临床价值
The Yinchenhao decoction
The Shuanghuanglian injection
Maternal-fetal ABO blood group incompatibility
Clinical value
作者简介
杨帆(1978-),女,广西玉林人,主治医师,研究方向为妇产科。